AS1411 Aptamer-Conjugated Liposomal siRNA Targeting MTA2 Suppresses PI3K/AKT Signaling in Pancreatic Cancer Cells. [PDF]
Kwak M, Hua TC, Jin H, Lee J, Kim DE.
europepmc +1 more source
Tumor-targeted aptamer-conjugated engineered bacteria for CXCL9 cytokine delivery in non-small cell lung cancer immunotherapy. [PDF]
Gu Q +7 more
europepmc +1 more source
Dual-Mode Aptamer AP1-F Achieves Molecular-Morphological Precision in Cancer Diagnostics via Membrane NCL Targeting. [PDF]
Yang Z, Wang L, Xiao C, Shen X.
europepmc +1 more source
Aptamer-liposome targeted nanotherapeutics for cancer therapy: Bibliometric analysis, recent developments and future perspectives. [PDF]
Gao Z +8 more
europepmc +1 more source
In vivo dynamic monitoring of self-assembled melatonin nanodrug combined with photothermal effects to alleviate hypoxia to attenuate tumor aggressiveness. [PDF]
Zeng Y +12 more
europepmc +1 more source
Nucleolin perturbation alters membrane lipid homeostasis.
Zahavi EE +14 more
europepmc +1 more source
Programmable DNAzyme nanocatalysts orchestrate redox-immune coupling for time-gated cancer immunomodulation. [PDF]
Wang L +8 more
europepmc +1 more source
Mechanisms and Design Principles of Proteolysis-Targeting Chimeras and Their Emerging Applications. [PDF]
Knoll N, Neamati N, Üren A.
europepmc +1 more source
Dual functionality of MDM2 in PROTACs expands the horizons of targeted protein degradation. [PDF]
Zhao J, Chen H, Liang C.
europepmc +1 more source
Microporous structures on mineralized collagen mediate bone restoration by promoting nucleolin secretion to induce macrophage M2 polarization. [PDF]
Li J +9 more
europepmc +1 more source

